ConductScience.org, home

Paper35697668

Plasmodium falciparum 7G8 challenge provides conservative prediction of efficacy of PfNF54-based PfSPZ Vaccine in Africa.

Silva JC and 13 others. Nat Commun, 2022. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Plasmodium falciparum 7G8 challenge provides conservative prediction of efficacy of PfNF54-based PfSPZ Vaccine in Africa. Papers, record 35697668. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35697668

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Plasmodium falciparum 7G8 challenge provides conservative prediction of efficacy of PfNF54-based PfSPZ Vaccine in Africa.
PubMed
Journal
Nat Commun
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, N.I.H., Intramural, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
0.91
iCite
Revised in PubMed
2026-08-01
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Silva JCJoana Chttps://orcid.org/0000-0001-6502-7026
2Dwivedi AAnkit
3Moser KAKara A
4Sissoko MSMahamadou S
5Epstein JEJudith E
6Healy SASara Ahttps://orcid.org/0000-0003-3078-6094
7Lyke KEKirsten E
8Mordmüller BBenjaminhttps://orcid.org/0000-0001-9101-2768
9Kremsner PGPeter Ghttps://orcid.org/0000-0002-3926-4113
10Duffy PEPatrick Ehttps://orcid.org/0000-0002-4483-5005
11Murshedkar TTooba
12Sim BKLB Kim Lee
13Richie TLThomas Lhttps://orcid.org/0000-0002-2946-5456
14Hoffman SLStephen Lhttps://orcid.org/0000-0002-0700-9505

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Malaria VaccinesMajor topic
Malaria, FalciparumMajor topic
Adult
Africa
Animals
Epitopes, T-Lymphocyte
Humans
Plasmodium falciparum
Sporozoites

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AI141900NIAID NIH HHSUnited StatesR01AI141900PubMed and NIHNIH RePORTER
R44 AI055229NIAID NIH HHSUnited StatesR44AI055229PubMed and NIHNIH RePORTER
R44 AI058375NIAID NIH HHSUnited StatesR44AI058375PubMed and NIHNIH RePORTER
U19 AI110820NIAID NIH HHSUnited StatesU19AI110820PubMed and NIHNIH RePORTER
ZIAAI001170NIHNIH RePORTER

Download CSV of grants

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133947856Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial.Nat Commun2021https://conductscience.org/library/papers/33947856PubMed
223929949Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine.Science2013https://conductscience.org/library/papers/23929949PubMed
318974882Proteomic profiling of Plasmodium sporozoite maturation identifies new proteins essential for parasite development and infectivity.PLoS Pathog2008https://conductscience.org/library/papers/18974882PubMed
49086149Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge.J Infect Dis1997https://conductscience.org/library/papers/9086149PubMed
528216244Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial.Lancet Infect Dis2017https://conductscience.org/library/papers/28216244PubMed
628719326Malaria-Related Hospitalizations in the United States, 2000-2014.Am J Trop Med Hyg2017https://conductscience.org/library/papers/28719326PubMed
717538895Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update.J Infect Dis2007https://conductscience.org/library/papers/17538895PubMed
831419294Dose-Dependent Infectivity of Aseptic, Purified, Cryopreserved Plasmodium falciparum 7G8 Sporozoites in Malaria-Naive Adults.J Infect Dis2019https://conductscience.org/library/papers/31419294PubMed
923060615A high-performance computing toolset for relatedness and principal component analysis of SNP data.Bioinformatics2012https://conductscience.org/library/papers/23060615PubMed
1023325771Total and putative surface proteomics of malaria parasite salivary gland sporozoites.Mol Cell Proteomics2013https://conductscience.org/library/papers/23325771PubMed
1127389903Overview, Control Strategies, and Lessons Learned in the CDC Response to the 2014-2016 Ebola Epidemic.MMWR Suppl2016https://conductscience.org/library/papers/27389903PubMed
1228199305Sterile protection against human malaria by chemoattenuated PfSPZ vaccine.Nature2017https://conductscience.org/library/papers/28199305PubMed
1332920641Multidose Priming and Delayed Boosting Improve Plasmodium falciparum Sporozoite Vaccine Efficacy Against Heterologous P. falciparum Controlled Human Malaria Infection.Clin Infect Dis2021https://conductscience.org/library/papers/32920641PubMed
1428431816Role of controlled human malaria infection (CHMI) in malaria vaccine development: A U.S. food & drug administration (FDA) perspective.Vaccine2017https://conductscience.org/library/papers/28431816PubMed
1528223498Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection.Proc Natl Acad Sci U S A2017https://conductscience.org/library/papers/28223498PubMed
1631782768Increase of Dose Associated With Decrease in Protection Against Controlled Human Malaria Infection by PfSPZ Vaccine in Tanzanian Adults.Clin Infect Dis2020https://conductscience.org/library/papers/31782768PubMed
1734801112Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial.Lancet Infect Dis2022https://conductscience.org/library/papers/34801112PubMed
1821903775Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity.Science2011https://conductscience.org/library/papers/21903775PubMed
1929943719Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of Plasmodium falciparum Sporozoite Vaccine in Tanzanian Adults.Am J Trop Med Hyg2018https://conductscience.org/library/papers/29943719PubMed
2028903777Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial.BMC Med2017https://conductscience.org/library/papers/28903777PubMed

See all 47 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
42611549Pan-African hybridization of PfSPZ increases antigenic diversity and replicative capacity for malaria vaccine design.JCI Insight2026https://conductscience.org/library/papers/42611549PubMed
41565496The endemic dilemma: why whole sporozoite malaria vaccine efficacy falls in the field.Trends Parasitol2026https://conductscience.org/library/papers/41565496PubMed
40098097Safety, tolerability and immunogenicity of a condensed, multi-dose prime regimen of PfSPZ Vaccine for the prevention of Plasmodium falciparum malaria infection.Malar J2025https://conductscience.org/library/papers/40098097PubMed
39753973Setting sights on a single-shot malaria vaccine.Nat Med2025https://conductscience.org/library/papers/39753973PubMed
39025972Malaria vaccines: a new era of prevention and control.Nat Rev Microbiol2024https://conductscience.org/library/papers/39025972PubMed
38514791A replication competent Plasmodium falciparum parasite completely attenuated by dual gene deletion.EMBO Mol Med2024https://conductscience.org/library/papers/38514791PubMed
37624021Malaria Genomics, Vaccine Development, and Microbiome.Pathogens2023https://conductscience.org/library/papers/37624021PubMed
37571809Sporozoite immunization: innovative translational science to support the fight against malaria.Expert Rev Vaccines2023https://conductscience.org/library/papers/37571809PubMed
37384799The exception that proves the rule: Virulence gene expression at the onset of Plasmodium falciparum blood stage infections.PLoS Pathog2023https://conductscience.org/library/papers/37384799PubMed
36159849Five decades of clinical assessment of whole-sporozoite malaria vaccines.Front Immunol2022https://conductscience.org/library/papers/36159849PubMed
35999221A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection.NPJ Vaccines2022https://conductscience.org/library/papers/35999221PubMed
35928033PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial.EClinicalMedicine2022https://conductscience.org/library/papers/35928033PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
DNAJC580331PubTator's text mininghttps://conductscience.org/library/genes/80331NCBI Gene
HLA-A3105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene
PLP15354PubTator's text mininghttps://conductscience.org/library/genes/5354NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35697668

GET https://conductscience.org/api/papers/v1/35697668/references?page=2